[1]
|
J. F. Ampelas, M. J. Wattiaux and A. P. Van Amerongen, “Psychiatric Manifestations of Lupus Erythematosus Systemic and Sjogren’s Syndrome,” Encephale, Vol. 27, No. 6, 2001, pp. 588-599.
|
[2]
|
J. G. Hanly, G. McCurdy, L. Fougere, J. A. Douglas and K. Thompson, “Neuropsychiatric Events in Systemic Lupus Erythematosus: Attribution and Clinical Significance,” Journal of Rheumatology, Vol. 31, No. 11, 2004, pp. 2156-2162.
|
[3]
|
E. C. Miguel, R. M. Pereira, C. A. Pereira, L. Baer, R. E. Gomes, L. C. de Sa, et al., “Psychiatric Manifestations of Systemic Lupus Erythematosus: Clinical Features, Symptoms, and Signs of Central Nervous System Activity in 43 Patients,” Medicine (Baltimore), Vol. 73, No. 4, 1994, pp. 224-232.
http://dx.doi.org/10.1097/00005792-199407000-00005
|
[4]
|
F. G. Nery, E. F. Borba, J. P. Hatch, J. C. Soares, E. Bonfa and F. L. Neto, “Major Depressive Disorder and Disease Activity in Systemic Lupus Erythematosus,” Comprehensive Psychiatry, Vol. 48, No. 1, 2007, pp. 14-19.
http://dx.doi.org/10.1016/j.comppsych.2006.04.002
|
[5]
|
ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature, “The American College of Rheumatology Nomenclature and Care Definitions for Neuropsychiatric Lupus Syndromes,” Arthritis & Rheumatism, Vol. 42, No. 4, 1999, pp. 599-608.
|
[6]
|
F. G. Nery, E. F. Borba, V. S. Viana, J. P. Hatch, J. C. Soares, E. Bonfa, et al., “Prevalence of Depressive and Anxiety Disorders in Systemic Lupus Erythematosus and Their Association with Anti-Ribosomal P Antibodies,” Progress in Neuro-Psychopharmacology & Biological Psychiatry, Vol. 32, No. 3, 2008, pp. 695-700.
http://dx.doi.org/10.1016/j.pnpbp.2007.11.014
|
[7]
|
N. N. Fatnoon, S. M. Azarisman and D. Zainal, “Prevalence and Risk Factors for Menstrual Disorders among Systemic Lupus Erythematosus Patients,” Singapore Medical Journal, Vol. 49, No. 5, 2008, pp. 413-418.
|
[8]
|
B. B. Dean, J. E. Borenstein, K. Knight and K. Yonkers, “Evaluating the Criteria Used for Identification of PMS,” Journal of Women’s Health (Larchmt), Vol. 15, No. 5, 2006, pp. 546-555.
http://dx.doi.org/10.1089/jwh.2006.15.546
|
[9]
|
U. Halbreich, J. Borenstein, T. Pearlstein and L. S. Kahn, “The Prevalence, Impairment, Impact, and Burden of Premenstrual Dysphoric Disorder (PMS/PMDD),” Psycho- neuroendocrinology, Vol. 28, No. S3, 2003, pp. 1-23.
http://dx.doi.org/10.1016/S0306-4530(03)00098-2
|
[10]
|
J. F. Mortola, “Premenstrual Syndrome,” Trends in Endocrinology & Metabolism, Vol. 7, No. 5, 1996, pp. 184-189. http://dx.doi.org/10.1016/1043-2760(96)00060-4
|
[11]
|
G. C. Valadares, L. Ferreira, H. Correa Filho and M. Romano-Silva, “Transtorno Disfórico Pré-Menstrual Revi- sao: Conceito, História, Epidemiologia e Etiologia,” Revista de Psiquiatria Clínica, Vol. 33, 2006, pp. 117-123.
http://dx.doi.org/10.1590/S0101-60832006000300001
|
[12]
|
K. Yonkers, P. M. O’Brien and E. Ericksson, “Premenstrual Syndrome,” The Lancet, Vol. 371, No. 9619, 2008, pp. 1200-1210.
http://dx.doi.org/10.1016/S0140-6736(08)60527-9
|
[13]
|
S. Girdler and R. Klatzkin, “Neurosteroid in the Context of Stress: Implications for Depressive Disorders,” Pharmacology & Therapeutics, Vol. 116, No. 1, 2007, pp. 125-139.
http://dx.doi.org/10.1016/j.pharmthera.2007.05.006
|
[14]
|
H. Ainiala, J. Loukkola, J. Peltola, M. Korpela and A. Hietaharju, “The Prevalence of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus,” Neurology, Vol. 57, No. 3, 2001, pp. 496-500.
http://dx.doi.org/10.1212/WNL.57.3.496
|
[15]
|
E. A. Bachen, M. A. Chesney and L. A. Criswell, “Prevalence of Mood and Anxiety Disorders in Women with Systemic Lupus Erythematosus,” Arthritis & Rheumatism, Vol. 61, No. 6, 2009, pp. 822-829.
http://dx.doi.org/10.1002/art.24519
|
[16]
|
U. Halbreich and J. Endicott, “Relationship of Dysphoric Premenstrual Changes to Depressive Disorders,” Acta Psychiatrica Scandinavica, Vol. 71, No. 4, 1985, pp. 331-338.
http://dx.doi.org/10.1111/j.1600-0447.1985.tb02532.x
|
[17]
|
M. N. Miller and B. E. Miller, “Premenstrual Exacerbations of Mood Disorders,” Psychopharmacological Bulletin, Vol. 35, No. 3, 2001, pp. 135-149.
|
[18]
|
L. A. Futterman and A. J. Rapkin, “Diagnosis of Premenstrual Disorders,” The Journal of Reproductive Medicine, Vol. 51, No. 4, 2006, pp. 349-358.
|
[19]
|
J. W. Bailey and L. S. Cohen, “Prevalence of Mood and Anxiety Disorders in Women Who Seek Treatment for Premenstrual Syndrome,” Journal of Women’s Health & Gender-Based Medicine, Vol. 8, No. 9, 1999, pp. 1181-1184. http://dx.doi.org/10.1089/jwh.1.1999.8.1181
|
[20]
|
J. Endicott, “The Menstrual Cycle and Mood Disorders,” Journal of Affective Disorders, Vol. 29, No. 2-3, 1993, pp. 193-200.
http://dx.doi.org/10.1016/0165-0327(93)90033-G
|
[21]
|
M. Pires and H. Calil, “Associacao Entre Transtorno Disfórico Pré-Menstrual e Transtornos Depressivos,” Revista Brasileira de Psiquiatria, Vol. 21, 1999, pp. 118-127.
http://dx.doi.org/10.1590/S1516-44461999000200011
|
[22]
|
D. G. Ayache and I. Costa, “Alteracoes da Personalidade no Lúpus Eritematoso Sistêmico,” The Brazilian Journal of Rheumatology, Vol. 45, No. 5, 2005, pp. 313-318.
|
[23]
|
M. Alpay and E. H. Cassem, “Diagnosis and Treatment of Mood Disorders in Patients with Rheumatic Disease,” Annals of the Rheumatic Diseases, Vol. 59, No. 1, 2000, pp. 2-4. http://dx.doi.org/10.1136/ard.59.1.2
|
[24]
|
D. P. Chapman, G. S. Perry and T. W. Strine, “The Vital Link between Chronic Disease and Depressive Disorders,” Preventing Chronic Disease, Vol. 2, No. 1, 2005, p. A14.
|
[25]
|
E. M. Tan, A. S. Cohen, J. F. Fries, A. T. Masi, D. J. Mc-Shane, N. F. Rothfield, et al., “The 1982 Revised Criteria for the Classification of Systemic Lupus Erythematosus,” rthritis & Rheumatism, Vol. 25, No. 11, 1982, pp. 1271-1277.
|
[26]
|
P. Amorim, “Mini International Neuropsychiatric Interview (MINI): Validacao de Entrevista Breve para Diagnóstico de Transtornos Mentais/Mini International Neuropsychiatric Interview (MINI): Validation of a Short Structured Diagnostic Psychiatric Interview,” The Revista Bra- sileira de Psiquiatria, Vol. 22, No. 3, 2000, pp. 106-115.
|
[27]
|
U. Halbreich, “The Etiology, Biology, and Evolving Pathology of Premenstrual Syndromes,” Psychoneuroendocrinology, Vol. 28, No. S3, 2003, pp. 55-99.
http://dx.doi.org/10.1016/S0306-4530(03)00097-0
|
[28]
|
I. Rodrigues and E. Oliveira, “Prevalência e Convivência de Mulheres com Síndrome Pré-Menstrual,” Arquivos de Ciências da Saúde, Vol. 13, No. 3, 2006, pp. 146-152.
|
[29]
|
S. F. Cal, A. P. Borges and M. B. Santiago, “Prevalência e classificacao da Depressao em Pacientes com Lúpus Eritematoso Sistêmico Atendidos em um Servico de Referência da Cidade de Salvador,” Jornal da LIRRNE, Vol. 2, 2006, pp. 36-43.
|
[30]
|
J. Bancroft, D. Rennie and P. Warner, “Vulnerability to Perimenstrual Mood Change: The Relevance of a Past History of Depressive Disorder,” Psychosomatic Medicine, Vol. 56, No. 3, 1994, pp. 225-231.
|
[31]
|
C. M. Nogueira and J. Pinto, “Prevalência dos Sintomas da Síndrome Pré-Menstrual,” Revista Brasileira de Ginecologia e Obstetricia, Vol. 22, 2000, pp. 347-351.
http://dx.doi.org/10.1590/S0100-72032000000600005
|
[32]
|
T. B. Pearlstein, “Hormones and Depression: What Are the Facts about Premenstrual Syndrome, Menopause, and Hormone Replacement Therapy?” American Journal of Obstetrics & Gynecology, Vol. 173, No. 2, 1995, pp. 646-653. http://dx.doi.org/10.1016/0002-9378(95)90297-X
|
[33]
|
S. A. Hartlage, K. E. Arduino and S. Gehlert, “Premenstrual Dysphoric Disorder and Risk for Major Depressive Disorder: A Preliminary Study,” Journal of Clinical Psychology, Vol. 57, No. 12, 2001, pp. 1571-1578.
http://dx.doi.org/10.1002/jclp.1119
|
[34]
|
F. Akdeniz and F. Karadag, “Does Menstrual Cycle Affect Mood Disorders?” Türk Psikiyatri Dergisi, Vol. 17, No. 4, 2006, pp. 296-304.
|
[35]
|
P. K. Braverman, “Premenstrual Syndrome and Premenstrual Dysphoric Disorder,” Journal of Pediatric & Adolescent Gynecology, Vol. 20, No. 1, 2007, pp. 3-12.
http://dx.doi.org/10.1016/j.jpag.2006.10.007
|
[36]
|
L. Plouffe Jr., K. Stewart, K. S. Craft, M. S. Maddox and J. L. Rausch, “Diagnostic and Treatment Results from a Southeastern Academic Center-Based Premenstrual Syndrome Clinic: The First Year,” American Journal of Obstetrics Gynecology, Vol. 169, No. 2, Pt. 1, 1993, pp. 295-303.
|
[37]
|
T. B. Pearlstein, U. Halbreich, E. D. Batzar, C. S. Brown, J. Endicott, E. Frank, et al., “Psychosocial Functioning in Women with Premenstrual Dysphoric Disorder before and after Treatment with Sertraline or Placebo,” The Journal of Clinical Psychiatry, Vol. 61, No. 2, 2000, pp. 101-109.
http://dx.doi.org/10.4088/JCP.v61n0205
|
[38]
|
A. D’Mello, L. Pinheiro and M. Lalined-Michaud, “Pre-Menstrual Mania: Two Case Report,” The Journal of Nervous and Mental Disease, Vol. 181, No. 5, 1993, pp. 330-331.
http://dx.doi.org/10.1097/00005053-199305000-00011
|
[39]
|
D. Conrad and A. H. Hamilton, “Recurrent Premenstrual Declive in Serum Lithium Concentration: Clinical Correlates and Treatment Implications,” Journal of the American Academy of Child Psychiatry, Vol. 25, No. 6, 1986, 852-853.
http://dx.doi.org/10.1016/S0002-7138(09)60206-5
|
[40]
|
M. Cutolo, S. Capellino, A. Sulli, B. Serioli, M. E. Secchi, B. Villaggio and R. H. Straub, “Estrogens and autoimmune diseases,” Annals of New York Academy of Sciences, Vol. 1089, 2006, pp. 538-547.
|
[41]
|
D. Moreira and J. Mello Filho, “Psicoimunologia Hoje,” In: Artmed Ed., Psicossomática Hoje, Porto Alegre, 1992, pp. 119-151.
|
[42]
|
S. O. Nunes, E. M. Reich, H. K. Morimoto, E. N. Itano, E. C. Xavier, C. M. Yamoshita, et al., “Immune and Hormonal Activity in Adults Suffering from Depression,” Brazilian Journal of Medical and Biological Research, Vol. 35, No. 5, 2002, pp. 581-587.
http://dx.doi.org/10.1590/S0100-879X2002000500011
|
[43]
|
A. Rapkin, “A Review of Treatment of Premenstrual Syndrome and Premenstrual Dysphoric Disorder,” Psychoneuroendcrinology, Vol. 28, Suppl. 3, 2003, pp. 39-53.
|
[44]
|
R. Glick, W. Harrison, J. Endicott, P. McGrath and F. M. Quitkin, “Treatment of Premenstrual Dysphoric Symptoms in Depressed Women,” Journal of American Medical Women’s Association, Vol. 46, No. 6, 1991, pp. 182-185.
|
[45]
|
N. Navarrete-Navarrete, M. I. Peralta-Ramírez, J. M. Sabio, I. Martínez-Egea, A. Santos-Ruiz and J. Jiménez-Alonso, “Quality-of-Life Predictor Factors in Patients with SLE and Their Modification after Cognitive Behavioural Therapy,” Lupus, Vol. 19, No. 14, 2010, pp. 1632-1639.
http://dx.doi.org/10.1177/0961203310378413
|